Hyperparathyroidism in renal failure.
出版信息
Br Med J. 1978 Feb 18;1(6110):390-1.
Abstract
摘要
相似文献
1
Hyperparathyroidism in renal failure.肾衰竭中的甲状旁腺功能亢进。
Br Med J. 1978 Feb 18;1(6110):390-1.
2
[Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].[肾功能不全中的继发性甲状旁腺功能亢进。预防与治疗]
MMW Munch Med Wochenschr. 1976 Jan 30;118(5):129-30.
3
When is Vitamin D contraindicated in dialysis patients?透析患者何时禁用维生素D？
Semin Dial. 2009 May-Jun;22(3):242-4. doi: 10.1111/j.1525-139X.2009.00564.x.
4
Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.日本透析治疗学会继发性甲状旁腺功能亢进治疗指南
Ther Apher Dial. 2007 Oct;11 Suppl 1:S44-7. doi: 10.1111/j.1744-9987.2007.00516.x.
5
Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.慢性透析患者继发性甲状旁腺功能亢进管理的临床实践指南
Ther Apher Dial. 2008 Dec;12(6):514-25. doi: 10.1111/j.1744-9987.2008.00648.x.
6
When is Vitamin D contraindicated in dialysis patients?透析患者何时禁用维生素D？
Semin Dial. 2009 May-Jun;22(3):249-51. doi: 10.1111/j.1525-139X.2009.00567.x.
7
When is Vitamin D Contraindicated in Dialysis Patients?透析患者何时禁用维生素D？
Semin Dial. 2009 May-Jun;22(3):245-7. doi: 10.1111/j.1525-139X.2009.00565.x.
8
When is Vitamin D contraindicated in dialysis patients?透析患者何时禁用维生素D？
Semin Dial. 2009 May-Jun;22(3):247-9. doi: 10.1111/j.1525-139X.2009.00566.x.
9
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
10
The need for better control of secondary hyperparathyroidism.更好地控制继发性甲状旁腺功能亢进的必要性。
Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V15-19. doi: 10.1093/ndt/gfh1051.
本文引用的文献
1
Circulating parathyroid hormone concentration in chronic renal insufficiency.慢性肾功能不全患者的循环甲状旁腺激素浓度
Arch Intern Med. 1969 Oct;124(4):417-22.
2
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. II. Factors affecting serum immunoreactive parathyroid hormone.慢性血液透析期间甲状旁腺功能亢进和骨病的病因学。II. 影响血清免疫反应性甲状旁腺激素的因素。
J Clin Invest. 1971 Mar;50(3):599-605. doi: 10.1172/JCI106530.
3
Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.
Ann Intern Med. 1970 Aug;73(2):225-33. doi: 10.7326/0003-4819-73-2-225.
4
Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease.慢性进行性肾病中的非抑制性继发性甲状旁腺功能亢进
Kidney Int. 1972;1(1):38-46. doi: 10.1038/ki.1972.6.
5
Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate.甲状旁腺激素分泌的调节：受钙的比例控制，不受磷酸盐影响。
Endocrinology. 1968 Nov;83(5):1043-51. doi: 10.1210/endo-83-5-1043.
6
Caclium, phosphorus, and bone in renal disease and transplantation.肾脏疾病与移植中的钙、磷和骨骼
Arch Intern Med. 1969 May;123(5):543-53.
7
Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.
Kidney Int. 1973 Aug;4(2):116-27. doi: 10.1038/ki.1973.90.
8
Azotaemic renal osteodystrophy: a quantitative study on iliac bone.氮质血症性肾性骨营养不良：髂骨的定量研究。
J Clin Pathol. 1973 Feb;26(2):83-101. doi: 10.1136/jcp.26.2.83.
9
The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease.
Kidney Int. 1973 Aug;4(2):141-5. doi: 10.1038/ki.1973.92.
10
Parathyroid function in renal insufficiency.肾功能不全时的甲状旁腺功能
Adv Nephrol Necker Hosp. 1974;4:171-84.
Zotero 插件